We are live on ! Find out more
PIMJS

PKO Investment Management Joint-Stock Portfolio holdings

AUM $1.38B
1-Year Est. Return 59.54%
This Fund
S&P 500
This Quarter Est. Return
+13.07%
1 Year Est. Return
+59.54%
3 Year Est. Return
+124.73%
5 Year Est. Return
+130.21%
10 Year Est. Return
+742.49%
AUM
$931M
AUM Growth
+$49.1M
Cap. Flow
-$51.7M
Cap. Flow %
-5.55%
Top 10 Hldgs %
40.41%
Holding
182
New
8
Increased
48
Reduced
68
Closed
7

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$14.7M
2
TMUS icon
T-Mobile US
TMUS
+$12.2M
3
ISRG icon
Intuitive Surgical
ISRG
+$7.79M
4
AMGN icon
Amgen
AMGN
+$7.55M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$5.39M

Sector Composition

Rank Sector Weight
1 Technology 27.09%
2 Materials 15.29%
3 Healthcare 13.03%
4 Consumer Discretionary 8.7%
5 Communication Services 8.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HCA icon
151
HCA Healthcare
HCA
$89.8B
$651K 0.07%
1,700
-1,600
-48% -$577K
CTRA
152
DELISTED
Coterra Energy
CTRA
$584K 0.06%
23,000
CGAU
153
Centerra Gold
CGAU
$4.25B
$567K 0.06%
79,000
-66,000
-46% -$451K
DVN icon
154
Devon Energy
DVN
$49.3B
$562K 0.06%
17,661
+4,000
+29% +$127K
CF icon
155
CF Industries
CF
$18.2B
$524K 0.06%
5,700
BMRN icon
156
BioMarin Pharmaceuticals
BMRN
$13.6B
$495K 0.05%
9,000
RIVN icon
157
Rivian
RIVN
$23.1B
$495K 0.05%
36,000
AAUC
158
Allied Gold Corp
AAUC
$3.14B
$495K 0.05%
+37,000
New +$523K
MCK icon
159
McKesson
MCK
$102B
$440K 0.05%
600
-900
-60% -$635K
H icon
160
Hyatt Hotels
H
$16.8B
$419K 0.05%
3,000
DRD
161
DRDGold
DRD
$2.1B
$384K 0.04%
28,814
-22,000
-43% -$325K
IDXX icon
162
Idexx Laboratories
IDXX
$45B
$375K 0.04%
700
-2,600
-79% -$1.24M
VTRS icon
163
Viatris
VTRS
$18.5B
$357K 0.04%
40,000
ILMN icon
164
Illumina
ILMN
$29.1B
$334K 0.04%
3,500
OVV icon
165
Ovintiv
OVV
$17.5B
$323K 0.03%
8,500
VEEV icon
166
Veeva Systems
VEEV
$39.2B
$288K 0.03%
1,000
-1,000
-50% -$248K
RH icon
167
RH
RH
$3.41B
$284K 0.03%
1,500
SIG icon
168
Signet Jewelers
SIG
$3.59B
$278K 0.03%
3,500
-3,500
-50% -$233K
VKTX icon
169
Viking Therapeutics
VKTX
$3.97B
$265K 0.03%
10,000
-5,000
-33% -$132K
TDOC icon
170
Teladoc Health
TDOC
$1.22B
$261K 0.03%
30,000
BF.B icon
171
Brown-Forman Class B
BF.B
$12.8B
$242K 0.03%
9,000
PVH icon
172
PVH
PVH
$3.76B
$172K 0.02%
2,500
-2,500
-50% -$181K
MRNA icon
173
Moderna
MRNA
$25.4B
$166K 0.02%
6,000
CPRI icon
174
Capri Holdings
CPRI
$1.77B
$133K 0.01%
7,500
-7,500
-50% -$124K
BAX icon
175
Baxter International
BAX
$13.9B
$121K 0.01%
4,000

Similar funds

PKO Investment Management Joint-Stock's Q2 2025 Portfolio in Review

As of Q2 2025, PKO Investment Management Joint-Stock held 182 positions worth $931M, up 5.6% from $882M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

PKO Investment Management Joint-Stock withdrew a net $51.7M in Q2 2025, closing 7 positions and reducing 68 holdings. Its most notable exit was Dell, an estimated $2.28M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Materials and Healthcare.

Against the trend, PKO Investment Management Joint-Stock opened a new position in T-Mobile US worth $11.9M.

  • PKO Investment Management Joint-Stock's largest Q2 2025 buy was T-Mobile US: 50,000 shares worth $11.9M.
  • PKO Investment Management Joint-Stock added most to Apple in Q2 2025, an estimated $14.7M increase.
  • PKO Investment Management Joint-Stock's biggest Q2 2025 reduction was Invesco NASDAQ 100 ETF, cutting an estimated $29.7M.
  • PKO Investment Management Joint-Stock fully exited Dell in Q2 2025, selling an estimated $2.28M.
  • PKO Investment Management Joint-Stock's ten largest holdings make up 40% of its $931M portfolio in Q2 2025.
  • PKO Investment Management Joint-Stock opened 8 new positions and closed 7 in Q2 2025.
  • PKO Investment Management Joint-Stock's portfolio value rose 5.6% quarter-over-quarter to $931M.

Based on PKO Investment Management Joint-Stock's 13F filing for Q2 2025, filed 31 Jul 2025.